ppGpp Extraction from Trichoderma Viride Mycelium

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for obtaining guanosine tetraphosphate (ppGpp) are inefficient and costly, particularly due to difficulties in producing high yields from bacteria and other organisms, and are hindered by ethical restrictions on transgenic organisms, while its high levels can inhibit growth and be toxic, limiting its agricultural applications.

Innovation Solution

A method involving the extraction of ppGpp from Trichoderma viride fungus culture using formic acid and ammonium acetate, followed by purification via weak anion exchange, allowing for cost-effective and high-yield production of this nucleotide.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If ppGpp is produced in bacterial systems, then the level of alarmones can be elevated under stressful conditions, but the production is inefficient and costly with difficulty in producing high yields

Engineering Contradiction:
Improveyield of ppGppVSAvoidproduction efficiency
Core Design Contradiction:
Quantity of substanceVSProductivity

Solution Approach 1:

The patent changes the biological system parameter from bacterial to fungal (Trichoderma viride), enabling high-yield production of ppGpp. The fungal system naturally accumulates ppGpp under stress conditions without the growth inhibition problems encountered in bacterial systems, achieving both high quantity and high productivity.

Inventive Principle:
Principle #35Parameter changes

2Quantity of substance

If transgenic organisms are used to increase ppGpp production, then yield can be elevated, but ethical restrictions limit their use

Engineering Contradiction:
Improveyield of ppGppVSAvoidapplicability constraints
Core Design Contradiction:
Quantity of substanceVSAdaptability or versatility

Solution Approach 1:

The patent uses a non-transgenic fungal system that can be easily cultivated and discarded after use, avoiding the ethical and regulatory complexities of transgenic organisms. The Trichoderma viride fungus serves as a temporary, disposable production system that meets agricultural needs without long-term environmental concerns.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Quantity of substance

If high levels of ppGpp are produced, then it can inhibit growth and be toxic, but this limits its agricultural applications

Engineering Contradiction:
Improveconcentration of ppGppVSAvoidtoxicity and growth inhibition
Core Design Contradiction:
Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The patent extracts ppGpp from the fungal culture and purifies it to obtain high concentrations of the compound without the accompanying toxic cellular components. This separation allows the agricultural application of pure ppGpp at effective concentrations while avoiding the harmful effects associated with whole-cell extracts or crude preparations.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method enables the efficient and cost-effective production of ppGpp from Trichoderma viride, overcoming the challenges of bacterial production limitations and ethical constraints, with Trichoderma viride being easier to cultivate and produce in large quantities, facilitating its use in agriculture for stress protection in crops.

Implementation Method 1

The mycelium is suspended in 1.5-2 N formic acid and incubated on ice preferably for 15 to 30 min

Methodology Applied
Scientific EffectSolvation: Solvation

Implementation Method 2

nucleotides are separated in such a manner that the mycelium is suspended in 1.5-2 N formic acid

Methodology Applied
Scientific EffectDissolution: Solvation

Implementation Method 3

purification based on weak anions exchange... ammonium acetate NH4OAc... are added and introduced into an already prepared SPE column

Methodology Applied
Scientific EffectIon exchange: Ion Exchange

Implementation Method 4

then centrifuged, and the supernatant is collected

Methodology Applied
Scientific EffectCentrifugal separation: Centrifugal Separation

Implementation Method 5

the thus prepared eluate is lyophilized

Methodology Applied
Scientific EffectFreeze drying: Freeze Drying

Data Source

PatentEP4477737A1The method of obtaining and extraction of secondary fungal metabolites
Publication Date: 2024.12.18 UNIV MIKOLAJA KOPERNIKA
  • EP4477737A1 patent drawing
  • EP4477737A1 patent drawing
  • EP4477737A1 patent drawing

AI summary

The subject of the invention is the method of obtaining and extraction of secondary fungal metabolites characterized in that the T. Viride mycelium in the amount 75-100 mg is shredded and nucleotides are separated in such a manner that the mycelium is suspended in 1.5-2 N formic acid and incubated on ice preferably for 15 to 30 min, then centrifuged and the supernatant is collected, and then ammonium acetate NH4OAc, the 13C ppGpp internal standard are added and introduced into an already prepared SPE column by rinsing with methanol MeOH and ammonium acetate in the amount from 35 to 60 mM, and then the column with the introduced sample is rinsed with ammonium acetate NH4OAc in the amount from 30 to 70 mM preferably 50 mM at the pH from 4 to 5 preferably pH 4.5 and methanol MeOH and nucleotides are eluted with a MeOH/ H2O/NH4OH solution, and the thus prepared eluate is lyophilized, dissolved in water and filtered in columns for DNA purification. Preferably the mycelium is shredded by grinding in a mortar preferably at the temperature from 20 to 25°C.